Font Size:
a
A
A
Keyword [pneumonitis]
Result: 141 - 160 | Page: 8 of 8
141.
Retrospective Analysis Of Toxicity And Efficacy Of Hypofractionated Radiotherapy Combined With Chemotherapy For Small Cell Lung Cancer
142.
Predictive Value Of Pulmonary CT Texture Features For Radiation Pneumonitis
143.
Clinical Characteristics Of Interstitial Pneumonitis With Autoimmune Features (IPAF) And Risk Factors Affecting Their Death
144.
Preliminary Analysis Of The Clinical And Immune Microenvironment Of Immune Checkpoint Inhibitors Pneumonitis
145.
The Role And Mechanism Study Of Ubiquitin Specific Peptidase 11 In Radiation Induced Pneumonitis
146.
Clinical Analysis For Treatment-related Pneumonitis Of Thoracic Radiotherapy Combined With Immune Therapy And Multi-omics Prediction For Radiation Pneumonitis
147.
The Predictive Value And Clinical Application Of Peripheral Blood Biomarkers In Immunotherapy Of Advanced Non-small Cell Lung Cancer
148.
The Application Study On PD-L1 Expression,Immunotherapy Efficacy And Complication Prediction In Non-small Cell Lung Cancer Based On CT Radiomics
149.
Clinical Features,Biomarker Of Adverse Outcome And BALF Cell Heterogeneity In Fibrotic Hypersensitivity Pneumonitis
150.
To Investigate The Clinical Study Of Baihe Gujin Decoction On Prevention And Treatment Of Radiation Pneumonitis Based On The Theory Of "Lung Dryness And Jin Injury"
151.
Prognostic And Radiomics Analysis Of Hypofractionated Radiotherapy Plus PD-1 Blockage In Advanced NSCLC
152.
Differential Study Of Pneumonia Due To Treatment Of Malignancy In The Context Of COVID-19
153.
Exploration Of Establishing A Characteristic Model Of Immune Checkpoint Inhibitor-related Pneumonitis Based On Radiomics And Clinical Parameters
154.
The Timing Of Durvalumab Administration Affects The Risk Of Pneumonitis In Patients With Locally Advanced Non-small Cell Lung Cancer: A Systematic Review And Meta-analysis
155.
Analysis Of Factors Related To Severe Pneumonitis In Stage Ⅲ And Ⅳ NSCLC Treated With Thoracic Radiotherapy Combined With Immunotherapy
156.
Research On The Role Of JAK/STAT3 Signaling Pathway In Th17/Treg Cell Mediated Radiation Pneumonitis
157.
Clinical Feature,prognostic Impact And Risk Factor Of Checkpoint Inhibitor Related Pneumonitis In Patients With Non-Small Cell Lung Cancer
158.
Analysis Of Risk Factors Of Immune-related Pneumonitis In Advanced Lung Cancer And Its Correlation With The Efficacy Of Immunotherapy
159.
Risk Factors For Radiation-Induced Lung Injury After Hypofractionated Radiotherapy In Breast Cancer
160.
Clinical Study On Baihe Gujin Decoction Plus Other Ingredients In The Prevention And Treatment Of Radiation Pneumonitis In Non-small Cell Lung Cance
<<First
<Prev
Next>
Last>>
Jump to